These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 711523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A study of the relationship between Goodwin's high-risk score and fetal outcome.
    Yeh SY, Forsythe A, Lowensohn RI, Hon EH.
    Am J Obstet Gynecol; 1977 Jan 01; 127(1):50-5. PubMed ID: 12660
    [Abstract] [Full Text] [Related]

  • 3. Goodwin's high risk score and neonatal outcome: an evaluation.
    Harish R, Misra PK, Malik GK.
    Indian Pediatr; 1989 Aug 01; 26(8):800-3. PubMed ID: 2620981
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of cardiotocography out of childbirth. Preliminary report].
    Pérez Segura JJ, Castellanos Rodríguez J, Hernández Rivera J, Andalón Rochín E.
    Ginecol Obstet Mex; 1975 Oct 01; 38(228):257-61. PubMed ID: 1205171
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Estrogen excretion in high-risk pregnancies. Maternal estrogen excretion in 24-hour-urine and infant data in high-risk pregancies].
    Geier G, Schuhmann R, Lehmann WD.
    Fortschr Med; 1973 Sep 27; 91(27):1073-6. PubMed ID: 4746759
    [No Abstract] [Full Text] [Related]

  • 7. Simple guidelines for detecting disease in the infant in the perinatal period.
    Robertson AF, Aziz EM.
    J Med Assoc Ga; 1974 Dec 27; 63(12):459-64. PubMed ID: 4612090
    [No Abstract] [Full Text] [Related]

  • 8. [Velasco-Candano test, a new indicator to show perinatal risk].
    Nazer J, García N, Las Heras J, Rizzardini M.
    Bol Med Hosp Infant Mex; 1974 Dec 27; 31(2):333-42. PubMed ID: 4473992
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Significance of composite scoring of biochemical monitoring in fetal distress].
    Zhu FQ.
    Zhonghua Fu Chan Ke Za Zhi; 1991 May 27; 26(3):136-9, 187. PubMed ID: 1874054
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Usefulness and limits of a fetal biophysical profile in the management of pregnancy at risk].
    Biagiotti R, Marinai S, Russo G, Acanfora L.
    Minerva Ginecol; 1992 May 27; 44(1-2):1-4. PubMed ID: 1508377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxytocin challenge test in monitoring high-risk pregnancies.
    Cooper JM, Soffronoff EC, Bolognese RJ.
    Obstet Gynecol; 1975 Jan 27; 45(1):27-33. PubMed ID: 1110815
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apgar score and infant mortality in Puerto Rico.
    Morales del Valle Z, Vázquez Calzada JL.
    P R Health Sci J; 1994 Sep 27; 13(3):175-81. PubMed ID: 7997499
    [Abstract] [Full Text] [Related]

  • 19. Prenatal identification of the fetus at risk.
    Nesbitt RE.
    Clin Perinatol; 1974 Sep 27; 1(2):213-28. PubMed ID: 4470055
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.